by Virginie Montiel, Arnaud Robert, Annie Robert, Anas
Nabaoui, Tourneux Marie, Natalia Morales Mestre, Maerckx Guillaume,
Pierre-François Laterre and Xavier Wittebole
Annals of Intensive Care volume 10,
Article number: 125 (2020) Published: 29
September 2020
Objective
Critically ill patients admitted in ICU because of COVID-19
infection display severe hypoxemic respiratory failure. The Surviving Sepsis
Campaign recommends oxygenation through high-flow nasal cannula over non-invasive
ventilation. The primary outcome of our study was to evaluate the effect of the
addition of a surgical mask on a high-flow nasal cannula system on oxygenation
parameters in hypoxemic COVID-19 patients admitted in ICU who do not require
urgent intubation. The secondary outcomes were relevant changes in PaCO2 associated
with clinical modifications and patient’s feelings.
Design
We prospectively assessed 21 patients admitted in our mixed
Intensive Care Unit of the Cliniques Universitaires Saint Luc.
Main results
While FiO2 was unchanged, we demonstrate a significant increase of PaO2 (from 59 (± 6), to 79 mmHg (± 16), p < 0.001), PaO2/FiO2 from 83 (± 22), to 111 (± 38), p < 0.001) and SaO2 (from 91% (± 1.5), to 94% (± 1.6), p < 0.001), while the patients were under the surgical mask. The SpO2 returned to pre-treatment values when the surgical mask was removed confirming the effect of the device rather than a spontaneous positive evolution.
Conclusion
A surgical mask placed on patient’s face already treated by
a High-flow nasal cannula device improves COVID-19 patient’s oxygenation
admitted in Intensive Care Unit for severe hypoxemic respiratory failure
without any clinically relevant side.
No comments:
Post a Comment